Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB(D429N) in Neisseria gonorrhoeae.
Mukherjee A, Blomqvist SOP, Helekal D, Rubin DHF, Bowcutt B, Palace SG, Grad YH
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.